Low-density lipoprotein (LDL) behavior after in vitro oxidation in three groups of diabetics

Il Farmaco - Tập 56 - Trang 471-474 - 2001
I Seghrouchni1, J Drai1, E Bannier1, I Garcia1, A Revol1
1Laboratoire de Biochimie, UF Lipides-Glucides, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite Cedex, France

Tài liệu tham khảo

Kannel, 1979, Diabetes and cardiovascular disease. The Framingham study, JAMA, 241, 2035, 10.1001/jama.1979.03290450033020 Giugliano, 1995, Diabetes mellitus, hypertension and cardiovascular diseases: which role for oxidative stress?, Metabolism, 44, 363, 10.1016/0026-0495(95)90167-1 Steinbrecher, 1984, Modification of low density lipoproteins by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl Acad. Sci. USA, 81, 3883, 10.1073/pnas.81.12.3883 Brown, 1983, Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis, Annu. Rev. Biochem., 52, 223, 10.1146/annurev.bi.52.070183.001255 Esterbauer, 1989, Continuous monitoring of in vivo oxidation of human low density lipoprotein, Free Radical Res., 6, 67, 10.3109/10715768909073429 Richard, 1992, Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid, Clin. Chem., 38, 704, 10.1093/clinchem/38.5.704 Zaman, 1993, Simultaneous determination of vitamins A and E and carotenoı̈ds in plasma by reversed-phase HPLC in elderly and younger subjects, Clin. Chem., 39, 2229, 10.1093/clinchem/39.11.2229